Detalhe da pesquisa
1.
Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma.
Int J Mol Sci
; 23(9)2022 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35563109
2.
Daratumumab for relapsed AL amyloidosis-When cumulative real-world data precedes clinical trials: A multisite study and systematic literature review.
Eur J Haematol
; 106(2): 184-195, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33090552
3.
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study.
Ann Hematol
; 99(6): 1273-1281, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32193630
4.
Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study.
Br J Haematol
; 172(1): 89-96, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26567759
5.
Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.
Am J Hematol
; 88(2): 130-4, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23345248
6.
Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas: a report of the Israeli Myeloma Study Group.
Leuk Lymphoma
; 63(14): 3448-3455, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075048
7.
Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing.
Nat Med
; 27(3): 491-503, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619369
8.
Incidence rates and clinical characteristics of primary gastrointestinal non-Hodgkin lymphoma: a population study.
Eur J Gastroenterol Hepatol
; 32(5): 569-574, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31895909
9.
Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life Study.
Clin Lymphoma Myeloma Leuk
; 20(11): e850-e857, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32624446
10.
Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia.
Leuk Res
; 82: 24-28, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31152919
11.
Classification of Solitary Plasmacytoma, Is it more Intricate than Presently Suggested? A Commentary.
J Cancer
; 9(21): 3894-3897, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30410592
12.
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel.
Anticancer Res
; 38(11): 6423-6429, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30396967
13.
Primary plasma cell leukemia in the era of novel agents for myeloma - a multicenter retrospective analysis of outcome.
Leuk Res
; 68: 9-14, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29501828
14.
Composite Nasopharyngeal plasmacytoma with nodal paraimmunoblastic variant of small lymphocytic lymphoma: A case report.
Oncol Lett
; 14(2): 1745-1747, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28789404
15.
Primary gastric lymphoma in a soldier presenting as acute gastrointestinal bleeding.
Disaster Mil Med
; 1: 4, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-28265419
16.
Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndrome.
Clin Lymphoma Myeloma Leuk
; 15(6): e95-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25819366
17.
Self HSP60 peptide serves as an immunogenic carrier for a CTL epitope against persistence of murine cytomegalovirus in the salivary gland.
Vaccine
; 23(27): 3508-18, 2005 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15855009